Chandra Hood

675 total citations
9 papers, 531 citations indexed

About

Chandra Hood is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Chandra Hood has authored 9 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Chandra Hood's work include Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lung Cancer Research Studies (3 papers). Chandra Hood is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lung Cancer Research Studies (3 papers). Chandra Hood collaborates with scholars based in United States, Denmark and Canada. Chandra Hood's co-authors include Govind Ragupathi, Philip O. Livingston, Mark G. Kris, Lee M. Krug, Barbara Pizzo, Vincent A. Miller, Leslie B. Tyson, Harold J. Jennings, Susan E. Krown and Jedd D. Wolchok and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Vaccine.

In The Last Decade

Chandra Hood

9 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chandra Hood United States 7 358 246 137 137 134 9 531
Yasuyuki Matsumoto United States 15 356 1.0× 180 0.7× 100 0.7× 69 0.5× 54 0.4× 36 563
Ichiro Azuma Japan 11 264 0.7× 180 0.7× 32 0.2× 171 1.2× 44 0.3× 16 564
Edward J. Wawrzynczak United Kingdom 12 284 0.8× 332 1.3× 30 0.2× 61 0.4× 169 1.3× 30 515
Vikram R. Rao United States 10 245 0.7× 335 1.4× 54 0.4× 75 0.5× 24 0.2× 13 533
Seon-Hee Kim South Korea 11 273 0.8× 149 0.6× 76 0.6× 164 1.2× 25 0.2× 25 488
Е. В. Моисеева Russia 10 178 0.5× 111 0.5× 43 0.3× 70 0.5× 36 0.3× 30 362
Bård Indrevoll Norway 10 213 0.6× 62 0.3× 78 0.6× 104 0.8× 199 1.5× 17 470
Ran Xu China 12 382 1.1× 60 0.2× 106 0.8× 150 1.1× 40 0.3× 25 654
M. KONISHI Japan 5 138 0.4× 258 1.0× 109 0.8× 74 0.5× 56 0.4× 10 497

Countries citing papers authored by Chandra Hood

Since Specialization
Citations

This map shows the geographic impact of Chandra Hood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra Hood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra Hood more than expected).

Fields of papers citing papers by Chandra Hood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra Hood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra Hood. The network helps show where Chandra Hood may publish in the future.

Co-authorship network of co-authors of Chandra Hood

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra Hood. A scholar is included among the top collaborators of Chandra Hood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra Hood. Chandra Hood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Ragupathi, Govind, K. Simon Yeung, Ping‐Chung Leung, et al.. (2008). Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine. 26(37). 4860–4865. 56 indexed citations
3.
Sabbatini, Paul, Govind Ragupathi, Chandra Hood, et al.. (2007). Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer. Clinical Cancer Research. 13(14). 4170–4177. 113 indexed citations
4.
Livingston, Philip O., Chandra Hood, & Govind Ragupathi. (2006). Botanicals as immunological adjuvants and immunomodulators.. Cancer Research. 66. 1306–1307. 1 indexed citations
5.
Livingston, Philip O., Chandra Hood, Lee M. Krug, et al.. (2005). Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy. Cancer Immunology Immunotherapy. 54(10). 1018–1025. 43 indexed citations
6.
Krug, Lee M., Govind Ragupathi, Chandra Hood, et al.. (2004). Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin. Clinical Cancer Research. 10(18). 6094–6100. 97 indexed citations
7.
Krug, Lee M., Govind Ragupathi, Kenneth Ng, et al.. (2004). Vaccination of Small Cell Lung Cancer Patients with Polysialic Acid orN-Propionylated Polysialic Acid Conjugated to Keyhole Limpet Hemocyanin. Clinical Cancer Research. 10(3). 916–923. 89 indexed citations
8.
Krug, Lee M., Govindaswami Ragupathi, Mark G. Kris, et al.. (2003). O-154 Development of a tetravalent small cell lung cancer (SCLC) vaccine containing GM2, fucosyl GM1, Globo H, and polysialic acid. Lung Cancer. 41. S47–S47. 1 indexed citations
9.
Ragupathi, Govind, Philip O. Livingston, Chandra Hood, et al.. (2003). Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.. PubMed. 9(14). 5214–20. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026